SEARCH

SEARCH BY CITATION

References

  • Benveniste H. (1989) Brain microdialysis. J. Neurochem. 52, 16671679.
  • Bonanno G., Fassio A., Severi P., Ruelle A. and Raiteri M. (1994) Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J. Neurochem. 63, 11631166.
  • Bunin M. A. and Wightman R. M. (1999) Paracrine neurotransmission in the CNS: involvement of 5-HT. Trends Neurosci. 22, 377382.
  • Burnet P. W., Eastwood S. L., Lacey K. and Harrison P. J. (1995) The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res. 676, 157168.
  • Di Chiara G., Tanda G. and Carboni E. (1996) Estimation of in vivo neurotransmitter release by brain microdialysis: the issue of validity. Behav. Pharmacol. 7, 640657.
  • Fisher R. E., Morris E. D., Alpert N. M. and Fischman A. J. (1995) In␣vivo imaging of neuromodulatory synaptic transmission using PET: a review of relevant neurophysiology. Human Brain Mapp. 3, 2434.
  • Gardner J. P., Fornal C. A. and Jacobs B. L. (1997) Effects of sleep deprivation on serotoninergic neuronal activity in the dorsal raphe nucleus of the freely moving cat. Neuropsychopharmacology 17, 7281.DOI: 10.1016/S0893-133X(97)00025-0
  • Ginovart N., Hassoun W., Le Bars D., Weissmann D. and Leviel V. (2000) In vivo characterization of p-[18F]MPPF, a fluoro analog of WAY-100635 for visualization of 5-HT1A receptors. Synapse 35, 192200.DOI: 10.1002/(SICI)1098-2396(20000301)35:3<192::AID-SYN4>3.3.CO;2-G
  • Glennon R. A. (1990) Serotonin receptors: clinical implications. Neurosci. Biobehav. Rev. 14, 3547.
  • Hamon M., Lanfumey L., El Mestikawy S., Boni C., Miquel M. C., Bolanos F., Schechter L. and Gozlan H. (1990) The main features of central 5-HT1 receptors. Neuropsychopharmacology 3, 349360.
  • Hillver S. E., Bjork L., Li Y. L., Svensson B., Ross S., Anden N. E. and Hacksell U. (1990) (S)-5-Fluoro-8-hydroxy-2-(dipropylamino) tetralin: a putative 5-HT1A receptor antagonist. J. Med. Chem. 33, 15411544.
  • Hume S., Hirani E., Opacka-Juffry J., Myers R., Townsend C., Pike V. and Grasby P. (2001) Effect of 5-HT on binding of [11C]WAY 100635–5-HT1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse 41, 150159.
  • Ichise M., Meyer J. H. and Yonekura Y. (2001) An introduction to PET and SPECT neuroreceptor quantification models. J. Nucl. Med. 42, 755763.
  • Kia H. K., Miquel M. C., Brisorgueil M. J., Daval G., Riad M., El Mestikawy S., Hamon M. and Vergé D. (1996) Immunocytochemical localization of serotonin-1A receptors in the rat central nervous system. J. Comp. Neurol. 365, 289305.
  • Kostowski W., Plaznik A. and Archer T. (1989) Possible implication of 5-HT1A function for the etiology and treatment of depression. New Trends Exp. Clin. Psychiatry 5, 91116.
  • Kung H. F., Stevenson D. A., Zhuang Z. P., Kung M. P., Frederick D. and Hurt S. D. (1996) New 5-HT1A receptor antagonist: [3H], P-MPPF. Synapse 4, 344346.
  • Laruelle M. (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab. 20, 423451.
  • Laruelle M. and Huang Y. (2001) Vulnerability of positron emission tomography radiotracers to endogenous competition. Q. J. Nucl. Med. 45, 124138.
  • Le Bars D., Lemaire C., Ginovart N., Plenevaux A., Aerts J., Brihaye C., Hassoun W., Leviel V., Mekhsian P., Weissmann D., Pujol J. F., Luxen A. and Comar D. (1998) High yeld radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY 100635. Nucl. Med. Biol. 25, 343350.
  • Le Bars D., Bonmarchand G., Alvarez J. M., Lemaire C. and Mosdzianowski C. (2001) New automation of 18F-MPPF using a coincidence synthesizer. J. Labelled Cpd. Radiopharm. 44, S1045.
  • Mathis C., Simpson N., Price J., Mahmood K., Bowman K. and Mintun M. (1995) Evaluation of [11C1]WAY 100635: a potent serotonin 5-HT1A receptor antagonist. J. Nucl. Med. 36, 162P (Abstract).
  • Meneses A. (1999) 5-HT system and cognition. Neurosci. Biobehav. Rev. 23, 1111125.
  • Meneses A. and Hong E. (1997) Role of 5-HT1A receptors in acquisition, consolidation and retrieval of learning. CNS Drugs Rev. 3, 6882.
  • Pain F., Laniece P., Mastrippolito R., Charon Y., Comar D., Leviel V., Pujol J. F. and Valentin L. (2000) SIC, an intracerebral radiosensitive probe for in vivo neuropharmacology investigations in small laboratory animals: theoretical considerations and physical characteristics. IEE Trans. Nucl. Sci. 47, 2532.
  • Palacios J. M., Waeber C., Hoyer D. and Mengod G. (1990) Distribution of serotonin receptors. Ann. NY Acad. Sci. 600, 3652.
  • Parsey R. V., Hwang D. R., Simpson N., Guo N. N., Mawlawi O., Kegeles L. S., Bergert B., Montoya S., Popilskis J., Mann J. J. and Laruelle M. (1999) PET studies of competition between [11C]carbonyl-WAY 100635 and endogenous serotonin. J. Nucl. Med. 40, 29P (abstract).
  • Passchier J. and Van Waarde A. (2001) Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system. Eur. J. Nucl. Med. 28, 113129.
  • Passchier J., Van Waarde A., Pieterman R. M., Elsinga P. H., Pruim J., Hendrikse N. H., Willemsen A. T. and Vaalburg W. (2000a) In vivo delineation of serotonin (5-HT1A) receptors in human brain with [18F]MPPF. J. Nucl. Med. 41, 18301835.
  • Passchier J., Van Waarde A., Pieterman R. M., Elsinga P. H., Pruim J., Hendrikse H. N., Willemsen A. T. M. and Vaalburg W. (2000b) Quantitative imaging of 5-HT1A receptor binding in healthy volunteers with [18F]-MPPF. Nucl. Med. Biol. 24, 473476.
  • Paxinos G. and Watson C. (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
  • Pazos A., Probst A. and Palacios J. M. (1987) Serotonin receptors in the␣human brain. III: Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21, 97122.
  • Peroutka S. J. (1995) Serotonin receptor subtypes. Their evolution and clinical relevance. CNS Drugs 4, 1828.
  • Plenevaux A., Lemaire C., Aerts J., Lacan G., Rubins D., Melega W. P., Brihaye C., Degueldre C., Fuchs S., Salmon E., Maquet P., Laureys S., Damhaut P., Weissmann D., Le Bars D., Pujol J. F. and Luxen A. (2000a) [18F]p-MPPF: a radiolabelled antagonist for the study of 5-HT1A receptors with PET. Nucl. Med. Biol. 27, 467471.
  • Plenevaux A., Weissmann D., Aerts J., Lemaire C., Brihaye C., Degueldre C., Le Bars D., Comar D., Pujol J. F. and Luxen A. (2000b) Tissue distribution, autoradiography and metabolism of 4-(2′-methoxyphenyl)-1-[N-(2′′pyridinyl)-p-[18F]fluorobenzamido]ethyl]piperazine (p-[18F]MPPF), a new serotonin 5-HT1A antagonist for positron emission tomography: an in vivo study in rats. J.␣Neurochem. 75, 803811.DOI: 10.1046/j.1471-4159.2000.0750803.x
  • Rowland N. E. and Carlton J. (1986) Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol. 27, 1362.
  • Rueter L. E., Fornal C. A. and Jacobs B. L. (1997) A critical review of 5-HT brain microdialysis and behavior. Rev. Neurosci. 8, 117137.
  • Saudou F. and Hen R. (1994) 5-Hydroxytryptaline receptor subtypes in vertebrates and invertebrates. Neurochem. Int. 25, 503532.
  • Saxena P. R. (1995) Serotonin receptors: subtypes, functional response and therapeutic relevance. Pharmacol. Ther. 66, 339368.
  • Seeman P., Guan H. C. and Niznik H. B. (1989) Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain. Synapse 3, 9697.
  • Seifritz E., Stahl S. M. and Gillin J. C. (1997) Human sleep EEG following the 5-HT1A antagonist pindolol: possible disinhibition of the raphe neuron activity. Brain Res. 759, 8491.
  • Shiue C. Y., Shiue G. G., Mozley P. D., Kung M. P., Zhuang Z. P., Kim H.␣ J. and Kung H. F. (1997) p-[18F]MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans. Synapse 25,␣147154.
  • Thielen R., Fangon N. B. and Frazer A. (1996) 4-(2′-methoxyphenyl)-1-[N-(2′′-pyridinyl)-p-iodobenzamido]ethyl]piperazine and 4-(2′-methoxyphenyl)-1-[2′′-pyridinyl)-p-fluorobenzamido]ethyl]piperazine, two new antagonist at pre- and post-synaptic serotonin-1A receptors. J. Pharmacol. Exp. Ther. 277, 661670.
  • Thomas H., Fink H., Sohr T. R. and Voits M. (2000) Lesion of the median raphe nucleus: a combined behavioral and microdialysis study in rats. Pharmacol. Biochem. Behav. 65, 1521.
  • Van Wijngaarden I., Tulp M. T. and Soudijn W. (1990) The concept of␣selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188, 301312.
  • Zhou F. C., Tao-Cheng J. H., Segu L., Patel T. and Wang Y. (1998) Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence. Brain Res. 805, 241254.
  • Zhuang Z. P., Kung M. P. and Kung H. F. (1994) Synthesis and evaluation of 4-(2′-methoxyphenyl)-1-[2′-[N-(2′′-pyridinyl)-p-iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand. J. Med. Chem. 37, 14061407.
  • Zimmer L., Hassoun W., Pain F., Bonnefoi F., Lanièce P., Mastrippolito R., Pinot L., Pujol J. F. and Leviel V. (2002) SIC, an intracerebral Β+-range-sensitive probe for radiopharmacology investigations in small laboratory animals: binding studies with [11C]raclopride. J.␣Nucl. Med. 43, in press.